Palatin WKN: A3DTUW ISIN: US6960775020 Kürzel: PTN Forum: Aktien User: allesaufaurora
0,948 USD
+3,61 %+0,033
23. Nov, 02:04:01 Uhr,
Nasdaq
Kommentare 565
c
A
ACP,
Montag 8:36 Uhr
0
We believe the pharmacological treatment of obesity is in the early stages of a multiyear cycle of innovation and will have a market value greater than $100 billion per year. We do have large companies that are very interested in the dry eye disease programs and then we have -- as well as the glaucoma and retinal.
So it may be a mixture. You may see a out-licensing of dry eye disease and then a corporate -- and a corporate combination of assets for the others that are a little bit earlier. Our expectation, not Nostradamus-confirmed, is that we're going to have multiple deals as we go forward. And some of them could be absolutely as early as the first quarter of next year.
A
ACP,
Montag 8:30 Uhr
0
As of September 30, 2024, Palatin's cash and cash equivalents were $2.4 million. Palatin did receive a scheduled $2.5 million deferred payment in November 2024 from Cosette Pharmaceuticals related to the sale of Vyleesi. Obviously, since this was received in November, it is not included in our September 30 cash and cash equivalents balance. Future investment and activities will be focused and limited to our core programs in obesity. We've retained an investment bank to conduct, explore and evaluate strategic options for our non-obesity programs. At this stage, there is significant interest in and ongoing discussions for our Phase III dry eye disease program, our early-stage glaucoma and retina development programs and our Phase II ulcerative colitis program from multiple parties.
M
c
Checker666,
2. Okt 8:33 Uhr
0
https://www.gurufocus.com/news/2539968/palatin-technologies-inc-ptn-q4-2024-earnings-call-transcript-highlights-strategic-moves-and-financial-performance
c
cabal06ba,
1. Okt 13:39 Uhr
0
"Palatin’s net loss for the quarter and fiscal year ended June 30, 2024, was $8.6 million and $29.7 million, or $(0.51) and $(2.02) per basic and diluted common share, respectively, compared to a net loss of $9.8 million and $24.0 million, or $(0.84) and $(2.21) per basic and diluted common share, respectively, for the same periods in 2023.
The decrease in net loss for the quarter ended June 30, 2024, over the quarter ended June 30, 2023, was mainly due to the decrease in Vyleesi operating expenses, offset by the elimination of net product revenue of Vyleesi and the recognition of the change in fair value of warrant liabilities for the quarter ended June 30, 2023.
The increase in net loss for the fiscal year ended June 30, 2024, over the prior fiscal year, was mainly due to the recognition of an income tax benefit related to the sale of New Jersey Net Operating Losses, and the recognition of a gain on purchase commitments for the fiscal year ended June 30, 2023."
c
cabal06ba,
1. Okt 13:34 Uhr
0
https://palatin.com/press_releases/palatin-reports-fourth-quarter-and-fiscal-year-ended-2024-financial-results-provides-update-on-clinical-programs-strategic-priorities-and-anticipated-milestones/
Geraldine1224,
27. Sep 23:26 Uhr
1
traderfox aktien-terminalhttps://aktie.traderfox.comaktien-terminal: das aktien ... - traderfox https://www.google.com/url?q=https://aktie.traderfox.com/&sa=u&ved=2ahukewj78nk6-oaiaxvd_7sihdfii2iqfnoecbqqaq&usg=aovvaw3gsrascafd_arfszo8kwbp
Das ist der Aktienterminal von trader fox
Da kannst du die wkn eingeben und Aktien super abchecken 👍👍👍
Geraldine1224,
27. Sep 23:23 Uhr
0
Bilanz-Analyse 2023
Cash-Quote
99 %
0 %25 %50 %75 %100 %
1,00 % aller Aktien sind besser bewertet. Ranking
Eigenkapitalquote
14 %
0 %25 %50 %75 %100 %
85,38 % aller Aktien sind besser bewertet. Ranking
c
cabal06ba,
27. Sep 19:08 Uhr
0
"Palatin’s net loss was $8.4 million, or $(0.53) per common share, compared to a net loss of $8.7 million, or $(0.76) per common share for the comparable period last year.
The decrease over the comparable quarter last year was mainly due to a larger operating loss in fiscal 2024 offset by the higher other income primarily from changes in the fair value of warrant liabilities."
c
cabal06ba,
27. Sep 19:06 Uhr
0
Dienstag wissen wir mehr.
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | MICROSTRATEGY Hauptdiskussion | +6,19 % | |
2 | für alle, die es ehrlich meinen beim Traden. | ||
3 | Aktien und Saunaclub alla Luci | ||
4 | Wolfspeed | +31,18 % | |
5 | SOFI - Social Finance | +3,93 % | |
6 | CRYPTOBLOX Mining | -4,92 % | |
7 | NVIDIA Hauptdiskussion | -3,22 % | |
8 | Canada Nickel Company Hauptdiskussion | +1,70 % | |
9 | NETLIST Hauptdiskussion | +13,00 % | |
10 | SQUARE INC. A Hauptdiskussion | -0,55 % | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | MICROSTRATEGY Hauptdiskussion | +6,03 % | |
2 | Wolfspeed | +30,02 % | |
3 | CRYPTOBLOX Mining | -4,92 % | |
4 | NVIDIA Hauptdiskussion | -3,22 % | |
5 | SQUARE INC. A Hauptdiskussion | -0,45 % | |
6 | RENK (für normale, sachliche Kommunikation!) | -1,95 % | |
7 | NETLIST Hauptdiskussion | +13,00 % | |
8 | Canada Nickel Company Hauptdiskussion | +1,70 % | |
9 | SOFI - Social Finance | +3,93 % | |
10 | LUMINAR (GORES METROPOULOS) | ±0,00 % | Alle Diskussionen |